Marinus Pharmaceuticals Inc (MRNS)
1.84
+0.11
(+6.36%)
USD |
NASDAQ |
Sep 27, 16:00
1.85
+0.01
(+0.54%)
After-Hours: 20:00
Marinus Pharmaceuticals Gross Profit (Quarterly): 7.321M for June 30, 2024
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 7.321M |
March 31, 2024 | 6.923M |
December 31, 2023 | 6.303M |
September 30, 2023 | 6.883M |
June 30, 2023 | 5.695M |
March 31, 2023 | 10.17M |
December 31, 2022 | 6.87M |
September 30, 2022 | 2.292M |
Date | Value |
---|---|
June 30, 2022 | 1.79M |
March 31, 2022 | 14.19M |
December 31, 2021 | 1.52M |
September 30, 2021 | 8.636M |
June 30, 2021 | |
March 31, 2021 | |
December 31, 2020 | 1.547M |
September 30, 2020 | 0.171M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
0.171M
Minimum
Sep 2020
14.19M
Maximum
Mar 2022
5.736M
Average
6.586M
Median
Gross Profit (Quarterly) Benchmarks
Chimerix Inc | -- |
Cellectar Biosciences Inc | -- |
Ocular Therapeutix Inc | 14.93M |
Jaguar Health Inc | 2.294M |
Seres Therapeutics Inc | -- |